Image pharmaphorum Editor Sales & Marketing Launch excellence: escaping the complexity trap IQVIA’s Sarah Rickwood and Markus Gores look at how to deliver consistent launch performance in an increasingly complex world. News Positive safety data for long-term use of MS drug Kesimpta Multiple sclerosis drug Kesimpta has shown promising safety data for patients who are exposed to it for extended periods. News Keytruda approved as first-line advanced cervical cancer the... The FDA has approved Merck’s Keytruda as a first-line therapy for advanced cervical cancer. Jobs Managing Editor The role of the Managing Editor is to act as the editorial figurehead for, and public face of, pharmaphorum and its associated publications, cultivating and maintaining relationships with key edito Load more results
Sales & Marketing Launch excellence: escaping the complexity trap IQVIA’s Sarah Rickwood and Markus Gores look at how to deliver consistent launch performance in an increasingly complex world.
News Positive safety data for long-term use of MS drug Kesimpta Multiple sclerosis drug Kesimpta has shown promising safety data for patients who are exposed to it for extended periods.
News Keytruda approved as first-line advanced cervical cancer the... The FDA has approved Merck’s Keytruda as a first-line therapy for advanced cervical cancer.
Jobs Managing Editor The role of the Managing Editor is to act as the editorial figurehead for, and public face of, pharmaphorum and its associated publications, cultivating and maintaining relationships with key edito
News Adcendo raises $135m for cancer ADCs, and other financings Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
